-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Cidara Therapeutics, Inc. quarterly/annual Revenues history and growth rate from Q1 2022 to Q4 2024.
- Cidara Therapeutics, Inc. Revenues for the quarter ending December 31, 2024 was -$7.49M, a 56.3% increase year-over-year.
- Cidara Therapeutics, Inc. Revenues for the twelve months ending December 31, 2024 was $1.28M, a 94.5% decline year-over-year.
- Cidara Therapeutics, Inc. annual Revenues for 2024 was $1.28M, a 94.5% decline from 2023.
- Cidara Therapeutics, Inc. annual Revenues for 2023 was $23.3M, a 63.9% decline from 2022.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)